Invacare Warned by FDA on Bed-Manufacturing Hazards

Invacare Corp. was warned by the U.S. Food and Drug Administration that manufacturing violations may result in fire and entrapment hazards in its electric beds. The company’s shares fell as much as 4 percent.

Invacare, based in Elyria, Ohio, failed to respond adequately to complaints about the flaws, which may be linked to patient deaths, the FDA said in a Dec. 15 letter posted today on the agency’s website.

One complaint alleged that an 11-year-old child died after becoming trapped by an Invacare bed rail. Another patient died after one of the company’s beds caught fire, according to the agency. Two other patients were taken to the hospital and treated for smoke inhalation and chest pain after the control box of an Invacare bed caught fire, the FDA said.

The company has 15 days to notify the FDA of steps it’s taking to correct violations at an Invacare site in Sanford, Florida, and to prevent further incidents. Failure to fix the flaw may result in “seizure, injunction, and/or civil money penalties,” the agency said.

Kelly Mize, a company spokeswoman, didn’t immediately respond to a voicemail message seeking comment.

Invacare fell $1.23, or 4 percent, to $29.44 at 11:10 a.m. in New York Stock Exchange composite trading. The stock gained 23 percent in the 12 months before today.

To contact the reporter on this story: Molly Peterson in Washington at mpeterson9@bloomberg.net

To contact the editor responsible for this story: Adriel Bettelheim at abettelheim@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.